PubMed for id: 267038

Year	Number of Results
1977	2
1987	1
1989	1
1990	3
1991	2
1992	3
1993	7
1994	8
1995	7
1996	8
1997	6
1998	9
1999	10
2000	7
2001	15
2002	5
2003	10
2004	9
2005	14
2006	15
2007	17
2008	7
2009	11
2010	15
2011	13
2012	10
2013	16
2014	17
2015	15
2016	11
2017	8
2018	10
2019	8
2020	9
2021	11
2022	7
2023	3
2024	0

1

Survivin expression at the mRNA level in tumors and the protein concentration in the serum and peritoneal fluid in patients with serous ovarian tumors.

Kruszniewska-Rajs C, Smycz-Kubanska M, Strzalka-Mrozik B, Strzelczyk J, Szanecki W, Witek A, Gola J, Mielczarek-Palacz A. Kruszniewska-Rajs C, et al. Ginekol Pol. 2023;94(6):435-441. doi: 10.5603/GP.a2022.0158. Epub 2023 Mar 17. Ginekol Pol. 2023. PMID: 36929784 Free article.

2

Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients.

Asante DB, Mohan GRKA, Acheampong E, Ziman M, Calapre L, Meniawy TM, Gray ES, Beasley AB. Asante DB, et al. Sci Rep. 2023 Feb 13;13(1):2552. doi: 10.1038/s41598-023-29416-z. Sci Rep. 2023. PMID: 36781954 Free PMC article.

3

Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder Cancer.

Yamashita T, Higashi M, Sugiyama H, Morozumi M, Momose S, Tamaru JI. Yamashita T, et al. Am J Pathol. 2023 Mar;193(3):350-361. doi: 10.1016/j.ajpath.2022.12.005. Epub 2022 Dec 28. Am J Pathol. 2023. PMID: 36586479 Free article.

4

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes.

Gonzalez-Bosquet J, Cardillo ND, Reyes HD, Smith BJ, Leslie KK, Bender DP, Goodheart MJ, Devor EJ. Gonzalez-Bosquet J, et al. Int J Mol Sci. 2022 Nov 26;23(23):14814. doi: 10.3390/ijms232314814. Int J Mol Sci. 2022. PMID: 36499142 Free PMC article.

5

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples.

Akahane T, Masuda K, Hirasawa A, Kobayashi Y, Ueki A, Kawaida M, Misu K, Nakamura K, Nagai S, Chiyoda T, Yamagami W, Hayashi S, Kataoka F, Banno K, Sugano K, Okita H, Kosaki K, Nishihara H, Aoki D. Akahane T, et al. J Gynecol Oncol. 2022 Jul;33(4):e50. doi: 10.3802/jgo.2022.33.e50. Epub 2022 Mar 21. J Gynecol Oncol. 2022. PMID: 35557033 Free PMC article.

6

Mucinous Tumor Coexisting With Mesonephric-like Proliferation/Tumor in the Ovary: A Novel Association.

Nilforoushan N, Liu L, Cheang G, Sui AC, Andersen J, Finkelman BS, Liu Y, Nasseri-Nik N, Vang R, Ronnett BM, Song W, Xing D. Nilforoushan N, et al. Am J Surg Pathol. 2022 Aug 1;46(8):1095-1105. doi: 10.1097/PAS.0000000000001903. Epub 2022 Apr 12. Am J Surg Pathol. 2022. PMID: 35405716 Free PMC article.

7

Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers.

Gomez R, Tejada MÁ, Rodríguez-García V, Burgués O, Santos-Llamas AI, Martínez-Massa A, Marín-Montes A, Tarín JJ, Cano A. Gomez R, et al. Int J Mol Sci. 2022 Feb 3;23(3):1742. doi: 10.3390/ijms23031742. Int J Mol Sci. 2022. PMID: 35163671 Free PMC article.

8

Adnexal Torsion Due to Borderline Mucinous Tumor of the Gonad in a Prepubertal Girl with Mixed Gonadal Dysgenesis (45,X/46,XY) and a Turner Phenotype.

Grenvik JM, Keenahan L, Adeyemi-Fowode O. Grenvik JM, et al. J Pediatr Adolesc Gynecol. 2022 Aug;35(4):492-495. doi: 10.1016/j.jpag.2022.01.002. Epub 2022 Jan 16. J Pediatr Adolesc Gynecol. 2022. PMID: 35045325

9

Cancer testis antigen XAGE-1 is a promising marker for the diagnosis and treatment of ovarian cancer.

Jumaa MG, Ramadhan MA. Jumaa MG, et al. J Med Life. 2021 Sep-Oct;14(5):710-715. doi: 10.25122/jml-2021-0304. J Med Life. 2021. PMID: 35027975 Free PMC article.

10

Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study.

Sina F, Cassani C, Comerio C, De Ponti E, Zanellini F, Delle Marchette M, Roversi G, Jaconi M, Arbustini E, Urtis M, Dell'Oro C, Zambetti B, Paniga C, Acampora E, Negri S, Lazzarin S, Cesari S, Spinillo A, Kotsopoulos J, Fruscio R. Sina F, et al. Int J Gynecol Cancer. 2022 Jan;32(1):41-47. doi: 10.1136/ijgc-2021-003153. Epub 2021 Nov 29. Int J Gynecol Cancer. 2022. PMID: 34845040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

309 results

Results by year